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Editorial
Psycho-somatic Medicine in Europe, Japan, and through-
out the world must deal with similar problems such as the
links between theoretical findings from different biologi-
cal fields and programs in the basic sciences, and, on the
other hand, progress in good clinical practice – from a
psychosomatic perspective. What this means is good bio-
psycho-social primary care, family and internal medicine,
and detection of psychosomatic mechanisms in the devel-
opment of different chronic diseases such as asthma,
hypertension, coronary heart disease, inflammatory
bowel disease, diabetes, atopic dermatitis and chronic
arthritis.
As we better understand the mechanisms of the develop-
ment in these diseases. especially the psychosocial influ-
ences, each country needs to develop a strategy to
implement this knowledge into its practice of medicine.
The conditions of the health care system in Germany dif-
fer from those of France and Japan. Thus, it seems neces-
sary to promote psychosomatic knowledge – conducting
convincing psychosomatic studies in different medical
fields – in the national health care system and in society.
To implement this it is necessary to have cooperation
between workers in government, in faculties/universities
and in medical associations. However, the basis is holistic
thinking about mind and body in the society. Japanese
culture is in accord with holistic thinking in Europe and
with the ideas of psychosomatic theory and practice in
Germany. Victor von Weizsäcker and Thure von Uexküll
in Germany and Yujiro Ikemi in Japan attempted to bring
psychosomatic thinking into clinical practice as an advan-
tage for all patients.
The differences between these earlier times and today in
psychosomatic research are that, (1) we need good data in
all medical fields to demonstrate psychosomatic interac-
tions in different diseases, (2) we need to show that spe-
cial psychosomatic strategies of treatment are useful for
special psychological, biological and social targets in these
diseases, and (3) to demonstrate in randomized psycho-
somatic clinical trials that treatment effects are compara-
ble to other, more usual, treatments (TAU). Only in this
way is it possible to bring psychosomatic experiences and
knowledge into the national and international guidelines
for special diseases, as have the European guidelines for
prevention of coronary heart diseases (Orth-Gomer et al.
2005) [1].
This is a program in many national and international psy-
chosomatic research centres and will be supported by the
national psychosomatic societies. The communication
and integration of these ongoing studies in journals such
as Bio Psycho Social Medicine and in international meet-
ings such as the World Conference on Psychosomatic
Medicine (WCPM) 2005 in Kobe, where the Japanese
Emperor gave support for this psychosomatic thinking,
and the dissemination within the Society seems necessary.
Psychosomatic networks such as the European Network
on Psychosomatic Medicine [2] help combine ideas and
foster actions to spread psychosomatic knowledge and
bring it into the society of various nations.
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The main target should be our patients, who should profit
from this forthcoming of Bio Psycho Social Medicine.
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